Expert Panel Reviews COVID-19 Vaccines, To Meet Again Friday | Read

Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer were taken up for consideration by a government-appointed panel of experts on Wednesday. Serum Institute which is making the vaccine 'Covishield' developed by Oxford University and pharma major AstraZeneca and Bharat Biotech which has partnered the Indian Council of Medical Research (ICMR) for its 'Covaxin' made presentations before the panel. Pfizer has sought more time to present their data.